210 related articles for article (PubMed ID: 23976993)
1. Fibrin clot structure and platelet aggregation in patients with aspirin treatment failure.
Neergaard-Petersen S; Ajjan R; Hvas AM; Hess K; Larsen SB; Kristensen SD; Grove EL
PLoS One; 2013; 8(8):e71150. PubMed ID: 23976993
[TBL] [Abstract][Full Text] [Related]
2. The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
Neergaard-Petersen S; Hvas AM; Kristensen SD; Grove EL; Larsen SB; Phoenix F; Kurdee Z; Grant PJ; Ajjan RA
Thromb Haemost; 2014 Dec; 112(6):1142-50. PubMed ID: 25187394
[TBL] [Abstract][Full Text] [Related]
3. Imbalance between Fibrin Clot Formation and Fibrinolysis Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease.
Neergaard-Petersen S; Larsen SB; Grove EL; Kristensen SD; Ajjan RA; Hvas AM
Thromb Haemost; 2020 Jan; 120(1):75-82. PubMed ID: 31733633
[TBL] [Abstract][Full Text] [Related]
4. Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease.
Grove EL; Hvas AM; Mortensen SB; Larsen SB; Kristensen SD
J Thromb Haemost; 2011 Jan; 9(1):185-91. PubMed ID: 20955349
[TBL] [Abstract][Full Text] [Related]
5. Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled study.
Franchi F; Rollini F; Cho JR; King R; Phoenix F; Bhatti M; DeGroat C; Tello-Montoliu A; Zenni MM; Guzman LA; Bass TA; Ajjan RA; Angiolillo DJ
Thromb Haemost; 2016 Mar; 115(3):622-31. PubMed ID: 26633836
[TBL] [Abstract][Full Text] [Related]
6. Plasma and whole blood clot strength measured by thrombelastography in patients treated with clopidogrel during acute coronary syndromes.
Lu D; Owens J; Kreutz RP
Thromb Res; 2013 Aug; 132(2):e94-8. PubMed ID: 23920429
[TBL] [Abstract][Full Text] [Related]
7. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
Larsen SB; Grove EL; Kristensen SD; Hvas AM
Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
[TBL] [Abstract][Full Text] [Related]
8. Reduced antiplatelet effect of aspirin during 24 hours in patients with coronary artery disease and type 2 diabetes.
Christensen KH; Grove EL; Würtz M; Kristensen SD; Hvas AM
Platelets; 2015; 26(3):230-5. PubMed ID: 24750015
[TBL] [Abstract][Full Text] [Related]
9. Plasma fibrin clot phenotype independently affects intracoronary thrombus ultrastructure in patients with acute myocardial infarction.
Zalewski J; Bogaert J; Sadowski M; Woznicka O; Doulaptsis K; Ntoumpanaki M; Ząbczyk M; Nessler J; Undas A
Thromb Haemost; 2015 Jun; 113(6):1258-69. PubMed ID: 25739375
[TBL] [Abstract][Full Text] [Related]
10. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
[TBL] [Abstract][Full Text] [Related]
11. Calprotectin and platelet aggregation in patients with stable coronary artery disease.
Larsen SB; Grove EL; Pareek M; Kristensen SD; Hvas AM
PLoS One; 2015; 10(5):e0125992. PubMed ID: 25970343
[TBL] [Abstract][Full Text] [Related]
12. Platelet aggregation is dependent on platelet count in patients with coronary artery disease.
Würtz M; Hvas AM; Kristensen SD; Grove EL
Thromb Res; 2012 Jan; 129(1):56-61. PubMed ID: 21917303
[TBL] [Abstract][Full Text] [Related]
13. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.
Perneby C; Wallén NH; Hofman-Bang C; Tornvall P; Ivert T; Li N; Hjemdahl P
Thromb Haemost; 2007 Dec; 98(6):1316-22. PubMed ID: 18064330
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
[TBL] [Abstract][Full Text] [Related]
15. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
[TBL] [Abstract][Full Text] [Related]
16. Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels.
Parker WAE; Schulte C; Barwari T; Phoenix F; Pearson SM; Mayr M; Grant PJ; Storey RF; Ajjan RA
Cardiovasc Diabetol; 2020 Jan; 19(1):3. PubMed ID: 31910903
[TBL] [Abstract][Full Text] [Related]
17. The ABO Locus is Associated with Increased Fibrin Network Formation in Patients with Stable Coronary Artery Disease.
Winther-Larsen A; Christiansen MK; Larsen SB; Nyegaard M; Neergaard-Petersen S; Ajjan RA; Würtz M; Grove EL; Jensen HK; Kristensen SD; Hvas AM
Thromb Haemost; 2020 Sep; 120(9):1248-1256. PubMed ID: 32604426
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet effect of aspirin in patients with coronary artery disease.
Grove EL
Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
[TBL] [Abstract][Full Text] [Related]
19. Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets.
Würtz M; Grove EL; Wulff LN; Kaltoft AK; Tilsted HH; Jensen LO; Hvas AM; Kristensen SD
JACC Cardiovasc Interv; 2010 Aug; 3(8):828-35. PubMed ID: 20723855
[TBL] [Abstract][Full Text] [Related]
20. The Influence of Haemoglobin A1c Levels on Platelet Aggregation and Platelet Turnover in Patients with Coronary Artery Disease Treated with Aspirin.
Neergaard-Petersen S; Hvas AM; Grove EL; Larsen SB; Gregersen S; Kristensen SD
PLoS One; 2015; 10(7):e0132629. PubMed ID: 26148094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
